Download Our DHN Survey Result 2024
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Over 6k Drug Manufacturers & 53k Retailers Using mDMLA Mobile App in Gujarat

Written by : Jayati Dubey

May 13, 2024

Category Img

The primary objective of the FDCA-mDMLA mobile app is to promote accountability, transparency, inclusivity, uniformity, and timeliness in regulatory processes.

Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr H G Koshia has revealed that over 6,000 drug manufacturers and more than 53,000 retail and wholesale licensees are actively utilizing the Gujarat FDCA-mDMLA mobile app.

Gujarat became the first state in India to issue online licenses for allopathic medicines through the FDCA-mDMLA mobile app. CM Bhupendra Patel launched this mobile application on Good Governance Day, December 25, 2023.

The app is not limited to allopathic medicine only. It also extends its benefits to ayurvedic medicine and cosmetic manufacturers and sellers, further enhancing the scope of e-governance in the state.

The primary objective of the FDCA-mDMLA mobile app is to promote accountability, transparency, inclusivity, uniformity, and timeliness in regulatory processes.

By consolidating all stakeholders, including manufacturers and retailers, onto a single platform, the app aims to facilitate easy access to regulatory information, licensing rules, procedures, and protocols.

Transition to m-Governance Model

The transition from e-governance to an m-governance model by Gujarat FDCA enables licensees to access regulatory information and track the status of their applications in real-time through a seamless mobile interface.

Previously, all operations were conducted offline, requiring applicants to visit the office in person, follow up on applications, and obtain licenses.

To streamline these processes, the Gujarat FDCA, in collaboration with the National Informatics Centre (NIC) of the Government of India, developed the web portal.

This portal facilitated the online issuance of licenses with transparency and regulatory oversight. The m-governance app builds upon this foundation, consolidating all online platforms into one for faster and real-time access to application status.

Highlights of the Mobile App

Under the leadership of Dr HG Koshia, Gujarat FDCA developed this mobile app encompassing 24 categories of licenses and functions.

These include online Extended Licensing Node (XLN), drug manufacturing license application (DMLA), iDMLA, COSMLA, AYUMLA, and CERTIFICATE.

Dr Koshia emphasized that all digitally signed licenses, certificates, and approvals can be obtained through the mobile app.

Additionally, applicants can track the status of their applications and access services provided under the Right of Citizens to Public Service (RCPS) Act through the app, enhancing transparency and efficiency.

One of the direct benefits of the FDCA-mDMLA mobile app is its contribution to ease of doing business (EODB) initiatives.

Manufacturers and drug sellers in Gujarat can now access operational information and services through their mobile devices, promoting convenience and accessibility.

By leveraging technology to streamline processes and enhance transparency, the app aims for efficient and effective regulatory management.

In a similar development, Gujarat FDCA announced in January this year that it would streamline the procurement process for medicines by introducing online availability of Non-Conviction Certificates (NCC) and Performance Certificates (PC) for pharmaceutical companies.


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024